Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Nanomedicine in the fight against thrombotic diseases

  • Increased risk of complications, death during delivery for women with epilepsy

  • Cognitive behavioral therapy for insomnia with psychiatric, medical conditions

  • Reducing stroke damage may be next for optical coherence tomography technology widely used in vision healthcare

  • Restraint, confinement still an everyday practice in mental health settings

  • Age-related cognitive decline tied to immune-system molecule

  • New study again shows: More strokes with intracranial stents

  • People over 65 with traumatic brain injuries hospitalized four times as often as younger people

  • Uncovering the mechanism of our oldest anesthetic

  • Researchers discover ways to regenerate corticospinal tract axons

  •